Literature DB >> 9293532

Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas.

T Itoi1, H Watanabe, M Yoshida, Y Ajioka, K Nishikura, T Saito.   

Abstract

The correlation of p53 protein expression and p53 mutation of 33 gall-bladder carcinomas was studied according to the depth of invasion and grade of cytological atypia. Overexpression of p53 protein was detected by immunostaining in seven (70.0%) of 10 intramucosal and in 16 (69.6%) of 23 invasive carcinomas. p53 mutation was detected in five (71.4%) of the seven intramucosal carcinomas with overexpression and in eight (50.0%) of the 16 invasive cancers with overexpression and in one (10%) of the 10 non-overexpressing carcinomas at exons 5-8 by nested polymerase chain reaction-single-strand conformation polymorphism. The overexpression of p53 protein was present in nine (56.3%) of 16 low-grade carcinomas and in 14 (82.3%) of 17 high-grade carcinomas. In cases of overexpression, p53 mutation was detectable in four (44.4%) of nine low-grade and in nine (64.3%) of 14 high-grade carcinomas. In total, p53 mutation was verified in 56.5% (13/23) of cases involving protein overexpression and in 10% (1/10) of cases of non-overexpression. The sensitivity of p53 mutation was 56.5% (13/23), the specificity was 90.0% (9/10) and the validity was 1.47. In conclusion, our study indicates that p53 protein overexpression correlates well with gene mutation and that p53 alteration may be related to increasing grade of cytologic atypia of carcinomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293532     DOI: 10.1111/j.1440-1827.1997.tb04535.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  10 in total

1.  Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary.

Authors:  Masayuki Nagahashi; Yoichi Ajioka; Istvan Lang; Zoltan Szentirmay; Miklos Kasler; Hiroto Nakadaira; Naoyuki Yokoyama; Gen Watanabe; Ken Nishikura; Toshifumi Wakai; Yoshio Shirai; Katsuyoshi Hatakeyama; Masaharu Yamamoto
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

2.  Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions.

Authors:  Mateja Legan; Bostjan Luzar; Vera Ferlan Marolt; Andrej Cor
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 3.  Pathology of gallbladder carcinoma: current understanding and new perspectives.

Authors:  Munita Meenu Bal; Mukta Ramadwar; Kedar Deodhar; Shailesh Shrikhande
Journal:  Pathol Oncol Res       Date:  2015-01-25       Impact factor: 3.201

4.  Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers.

Authors:  Luis A Hidalgo Grau; Josep M Badia; Carmen Admella Salvador; Teresa Soler Monsó; Josep Feliu Canaleta; Josep M Gubern Nogués; Javier Suñol Sala
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

5.  Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas.

Authors:  Geraldo Ishak; Mariana Ferreira Leal; Ney Pereira Carneiro Dos Santos; Samia Demachki; Caroline Aquino Moreira Nunes; Barbara do Nascimento Borges; Danielle Queiroz Calcagno; Marília Cardoso Smith; Paulo Pimentel Assumpção; Rommel Rodríguez Burbano
Journal:  Clin Exp Med       Date:  2014-09-09       Impact factor: 3.984

6.  Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers.

Authors:  Junko Umeda; Takao Itoi; Atsushi Sofuni; Fumihide Itokawa; Toshio Kurihara; Takayoshi Tsuchiya; Kentaro Ishii; Shujiro Tsuji; Nobuhito Ikeuchi; Reina Tanaka; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Toshitaka Nagao; Hisashi Oshiro; Fuminori Moriyasu
Journal:  J Oncol       Date:  2013-12-18       Impact factor: 4.375

Review 7.  Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

Authors:  Aarti Sharma; Kiran Lata Sharma; Annapurna Gupta; Alka Yadav; Ashok Kumar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

Review 8.  Diagnosis and surgical management of gallbladder cancer: a review.

Authors:  Kaye M Reid; Antonio Ramos-De la Medina; John H Donohue
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

9.  Mitotic count reflects prognosis of gallbladder cancer particularly among patients with T3 tumor.

Authors:  Keita Kai; Masanori Masuda; Takao Ide; Yukari Takase; Atsushi Miyoshi; Kenji Kitahara; Kohji Miyazaki; Hirokazu Noshiro; Osamu Tokunaga
Journal:  Mol Clin Oncol       Date:  2013-05-16

10.  Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.

Authors:  Patricia García; Carolina Bizama; Lorena Rosa; Jaime A Espinoza; Helga Weber; Javier Cerda-Infante; Marianela Sánchez; Viviana P Montecinos; Justo Lorenzo-Bermejo; Felix Boekstegers; Marcela Dávila-López; Francisca Alfaro; Claudia Leiva-Acevedo; Zasha Parra; Diego Romero; Sumie Kato; Pamela Leal; Marcela Lagos; Juan Carlos Roa
Journal:  Biol Res       Date:  2020-04-15       Impact factor: 5.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.